A-Z
- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- R
- S
- T
- U
- V
- W
- X
- Y
- Z
- 0-9
Classification
Publication

- Full text
- Title
- Author
- ISBN/ISSN
- Publisher
AdvancedSearch
- AdvancedSearch
- Search help

Journal of Pain Management (01-2017)

Period of time： 2017年4期

Publisher： Nova Science Publishers, Inc.

Founded in： 2008

Total resources： 16

Period： Quarterly

E-ISSN： 1939-5914|10|4

ISSN： 1939-5914

Subject： R4 Clinical Medicine

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Current directory

How can we advance the adoption of medical cannabis into clinical practice?

The need to conduct high quality scientific research

The need to collect accurate patient-reported outcomes

The need to produce a variety of efficacious medical cannabis products

ORIGINAL ARTICLES

Patient characteristics from a medical cannabis provider

Patient conditions

Table 1. Patient age distribution by sex

Table 2. Patient lifestyle demographics

Table 3. Patient ethnicities

Table 4. Patient medical conditions

Patient symptoms

Table 5. Patient symptoms and distribution of symptom severities

Symptom clusters in patient-reported outcomes of medical cannabis patients

Table 1. Patient demographics (n = 863)

Table 2. Descriptive analysis of symptom scores at baseline (n = 863)

Table 3. Spearman correlation among 10 symptoms with p-values (Total n = 863)

Table 4. Eigenvalues and proportions of variance for 10 components

Table 5. Factor loadings and final communality

The use of medical cannabis in cancer patients

Patient population

Statistical analysis

Table 1. Patient demographics

Pain and ability to cope with pain

Table 2. Changes in pain severity and the ability to cope with pain at baseline and 4-month FU

Table 3. Improvement in medical conditions at 4-month FU

Table 4. Symptom severity at baseline

Table 5. Improvements in symptoms at four months

Improvements in medical conditions

Improvements in symptoms

Table 6. Quality of life (QOL) and associated factors at baseline and follow-up

Table 7. Experience with quality of life factors

Table 8. Side effects at follow-up

Improvement in quality of life (QOL)

Acknowledgments

The use of medical cannabis in common medical conditions excluding cancer

Patient population

Statistical analysis

Pain and ability to cope with pain

Table 1. Patient demographics

Improvements in medical conditions

Improvements in symptoms

Table 2. Changes in pain severity and the ability to cope with pain at baseline and FU

Table 3. Improvement in medical conditions at 4-month FU

Table 4. Symptom severity at baseline

Improvement in quality of life (QOL)

Table 5. Improvements in symptoms at FU

Table 6. Quality of life and associated factors at baseline and FU

Table 7. Experience with quality of life factors at baseline and FU

Table 8. Side effects at 4-month and 10-month FU

Table 9. Severity of side effects at 4-month FU

Acknowledgments

Efficacy of different varieties of medical cannabis in relieving symptoms

Table 1. Baseline demographics of patients who indicated cannabis varieties associated with symptom improvement

Properties of cannabis varieties to which improvement was most often attributed

Improvements in conditions, symptoms, and QOL items

Improvements in pain as a symptom at 4 months and 10 months

Table 2. Properties of fifteen most popular cannabis strains perceived to be most beneficial overall

Table 3. Top three cannabis strains associated with condition improvement

Table 4. Top three cannabis strains associated with symptom improvement

Table 5. Top three strains associated with QOL improvement

Table 6. Top ten strains associated with pain improvement at 4-month follow-up and 10-month follow-up

Medical cannabis use for patients with post-traumatic stress disorder (PTSD)

Patient population

Statistical analysis

Table 1. PTSD patient demographics

Pain and ability to cope with pain

Improvement in medical conditions

Improvements in quality of life (QOL)

Improvement in symptoms

Table 2. Pain response and ability to cope with pain at baseline, 4-month follow-up, and 10-month follow-up

Table 3. Improvement in most common medical conditions at 4-month follow-up

Table 4. Improvement in quality of life at 4-month and 10-month follow-up

Table 5. Improvement in experience with sleep, appetite, concentration, bowel activity, and sexual function

Table 6. Severity of most common symptoms at baseline

Table 7. Improvement in most common symptoms from baseline to 4-month and to 10-month follow-up

Table 8. Most common side effects at 4-month follow-up

Acknowledgments

Medical cannabis use in military and police veterans diagnosed with post-traumatic stress disorder (PTSD)

Data collection

Statistical methods

Medical cannabis use

Table 1. Demographic Information (n = 100)

Table 2. Time to follow-up (n = 100)

Improvement in PTSD-related symptoms and pain

Table 3. Dose of medical cannabis at follow-up (n = 99)

Table 4. Composition of medical cannabis varieties

Impact of PTSD on social and family life

Table 5. Severity of symptoms at baseline and follow-up (Scale of 0-10)

Table 6. Impact of PTSD on several domains of social and family life at baseline and follow-up (Scale of 0-10)

Table 7. Number of PTSD-related medications at baseline and at follow-up for patients with medication lists available (n = 87)

Reduction in PTSD-related medication use

Acknowledgments

The effect of medical cannabis on alcohol and tobacco use in veterans with post-traumatic stress disorder (PTSD)

Data collection

Statistical analysis

Table 1. Baseline information on patient demographics

Previous treatment prevalence and effectiveness

Table 2. Prevalence and effectiveness of previous PTSD treatments (Total n = 82)

Table 3. Preferred method of medical cannabis use (Total n = 97)

Table 4. Top five preferred varieties of medical cannabis by patients and characteristics (Total n = 86)

Table 5. Average alcohol and tobacco use at baseline and follow-up

Medical cannabis use

Improvement in alcohol and tobacco use

Acknowledgments

Efficacy of different varieties of medical cannabis in relieving symptoms in post-traumatic stress disorder (PTSD) patients

Patient population

Statistical analysis

Improvement of PTSD and its common symptoms

Preferred varieties for relief of PTSD

Preferred varieties for relief of common PTSD symptoms

Table 1. Change in severity of PTSD and the four most commonly experienced symptoms of PTSD patients

Table 2. Varieties most helpful for PTSD at 4 months and 10 months and composition of each variety (% indica, sativa, THC, CBD)

Table 3. Varieties most helpful for PTSD symptoms and composition of each variety

Table 4. Dosage of medical cannabis in PTSD versus non-PTSD patients

Usage of medical cannabis

Acknowledgement